Eisai-arkiv - BioStock

Ablivas CEO: "We remain on track for the interim analysis early in Q3"

Eisai’s regulatory progress brings cash flow for BioArctic

26 September, 2023

Shortage of Alzheimer's patients

Alzheimer’s studies cry out for patients

5 June, 2023

Eli Lilly presents positive results in Alzheimer´s

Positive results for Eli Lilly in Alzheimer’s

12 May, 2023

FDA

Fewer approvals in 2022 from cautious FDA

11 January, 2023

Strongest Swedish Life Science stocks of 2022

Sweden’s 10 strongest life science stocks 2022

2 January, 2023

Alzheimers breakthrough

A breakthrough in Alzheimer’s drug development?

21 December, 2022

Best swedish life science stocks in the summer of 2022

The 5 best life science stocks so far in 2022

3 October, 2022

BioArtctic soars on phase III results

BioArctic soars amid positive phase III results with lecanemab

28 September, 2022